Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to…
GAITHERSBURG, Md.–(BUSINESS WIRE)–Viela Bio today announced that data from the N-MOmentum trial—the largest global, placebo-controlled study conducted in patients with…
In the Phase III CASPIAN trial IMFINZI at a fixed, convenient dose improved survival with either a cisplatin or carboplatin…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging, announced that…
Dr. Coles assumes his new role at an important time as the company prepares to launch six clinical trials by…
DUBLIN–(BUSINESS WIRE)–The “Global Specialty Pharmaceutical Partnering Terms and Agreements 2014-2019: Deal trends, players and financials” report has been added to…
Phase 3 Data for KEYTRUDA® (pembrolizumab) as Neoadjuvant Therapy in Combination with Chemotherapy in Patients with Triple-Negative Breast Cancer (KEYNOTE-522)…
Steven Altschuler, M.D., Managing Director of Ziff Capital Partners and Chairman of Spark Therapeutics, joins PBG’s Board of Directors CAMBRIDGE,…
NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to…
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Pharmaceutical & Cosmetics Industrial Robots Market 2014-2025 by End-user, Application, Product Type and Country” report has been…